Epilepsy

33 competing products in clinical development for Epilepsy.

Pipeline by Phase

Pre-clinical3

Phase 27

Phase 39

Approved14

All Products (33)

Product	Company	Stage	Status	Hype
Perampanel Oral Tablet	Eisai	Approved	Completed	43
Perampanel	Eisai	Approved	Completed	43
zonisamide low dose group + zonisamide high dose group	Eisai	Approved	Completed	43
zonisamide	Eisai	Approved	Completed	43
Perampanel	Eisai	Approved	Completed	43
Zonisamide	Eisai	Approved	Completed	43
Zonisamide + Topiramate	Eisai	Approved	Completed	43
Zonegran	Eisai	Approved	Completed	43
zonisamide + carbamazepine	Eisai	Approved	Completed	43
Zonisamide + Sodium valproate	Eisai	Approved	Completed	43
Lacosamide	UCB	Phase 3	Completed	40
Placebo + Rufinamide	Eisai	Phase 3	Completed	40
perampanel	Eisai	Phase 3	Completed	40
Zonisamide + Carbamazepine	Eisai	Phase 3	Completed	40
Zonisamide + Lamotrigine	Eisai	Phase 3	Completed	40
Zonisamide + Carbamazepine	Eisai	Phase 3	Completed	40
Perampanel	Eisai	Phase 3	Completed	40
perampanel	Eisai	Phase 2	Completed	35
Zonegran	Eisai	Approved	Terminated	35
perampanel	Eisai	Approved	Terminated	35
E2007 + Placebo	Eisai	Phase 2	Completed	35
E2007 (perampanel) + Placebo	Eisai	Phase 2	Completed	35
Perampanel	Eisai	Phase 2	Completed	35
E2007 + E2007 + Placebo	Eisai	Phase 2	Completed	35
Zonisamide at targeted daily doses of 100-500 mg/day + Placebo administered to match targeted daily doses of 100-500 mg/day	Eisai	Approved	Terminated	35
Perampanel + Placebo	Eisai	Phase 2	Completed	35
Perampanel 1 week titration + Perampanel 2 week titration + Perampanel 4mg + Placebo	Eisai	Approved	Terminated	35
Perampanel + Perampanel	Eisai	Phase 2	Completed	35
Zonisamide + Placebo	Eisai	Phase 3	Terminated	32
Zonisamide + Placebo	Eisai	Phase 3	Terminated	32
Perampanel	Eisai	Pre-clinical	Completed	26
Fycompa	Eisai	Pre-clinical	Completed	26
Perampanel	Eisai	Pre-clinical	Completed	26